Key Takeaways
- Biotalys has appointed Luc Van Fraeyenhoven as its new Chief Financial Officer (CFO), succeeding Douglas Minder.
- Van Fraeyenhoven brings over 30 years of experience in finance across biotechnology, medtech, and the automotive sectors.
- He has previously served in CFO roles at ActoBio Therapeutics, Arseus Medical, and most recently, the Kebony Group.
- Leadership at Biotalys views this appointment as strategic ahead of commercializing its first protein-based biocontrol products.
- Douglas Minder is stepping down to pursue other career opportunities after contributing to operational streamlining and financial runway extension.
Biotalys Names Luc Van Fraeyenhoven as New CFO
Biotalys (Profile), a Belgium-based AgTech company focused on protein-based biocontrols, announced the appointment of Luc Van Fraeyenhoven as Chief Financial Officer. He will succeed outgoing CFO Douglas Minder, with a planned transition over the coming months.
Van Fraeyenhoven steps into the role with more than three decades of financial leadership across biotechnology, medical technology, and the automotive sector.
Sees Strategic Fit in Van Fraeyenhoven’s Background
Throughout his career, Luc Van Fraeyenhoven has held senior financial roles at companies such as ActoBio Therapeutics, Arseus Medical, and the Akkermansia Company. He most recently served as CFO at the Kebony Group, and previously held positions of increasing responsibility at Volvo Cars, including CFO for its European commercial operations.
Simon Moroney, Chairman of the Board at Biotalys, stated: “Luc joins us at an important juncture in the company as we continue to advance our innovative product pipeline… We are grateful to Douglas for his many contributions to Biotalys, particularly as we streamlined operations and extended our financial runway.”
Aligns Financial Leadership with Commercialization Plans
The appointment comes as Biotalys moves toward the commercialization of its first crop protection products. The company is developing a pipeline of sustainable biocontrols designed to reduce reliance on conventional chemical pesticides.
Kevin Helash, CEO of Biotalys, commented: “Luc will be a valuable partner for the management and board as we continue to best position the company for the commercialization of our first products… His extensive experience with other companies in the biotechnology arena is an outstanding fit for Biotalys.”
Van Fraeyenhoven Looks Ahead to Advancing Biotalys’ Mission
Expressing enthusiasm for the role, Luc Van Fraeyenhoven said: “I am delighted to join the Biotalys team and am eager to be a partner with and resource to the entire organization. Biotalys occupies a unique position in the agricultural and biotech space, and I look forward to contributing to the advancement of this novel, sustainable technology.”
4 Comments